The primary objective was to demonstrate superiority of semaglutide 7.2 mg against placebo on weight loss after 72 weeks with respect to the percentage change in body weight and the proportion of participants achieving weight loss of 5% or greater
86 percent of the active group achieved a reduction of at least 5 percent in this model
Asoorbyl Glucoside, Maltodextrin, Glutathione, Gardenio Florida Fruit Extract, Ascorbic Acid, Tronexamic Acid, Tocopheral
Most patients do not need to discontinue GLP-1 therapy for modest heart rate increases
In this seven-day high-protein meal plan, we map out a week of meals and snacks tailored to support people taking GLP-1 medications
In the eighth trial of the STEP program (for the Semaglutide Treatment Effect in People with obesity), researchers compared semaglutide directly to liraglutide in comparable doses.19 After 68 weeks, participants on liraglutide lost an average of 6.4% body weight, but those on semaglutide saw nearly triple that effect, losing an average of 15.8% of body weight